Optimal respiratory-gated [18F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Optimal respiratory-gated [18F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma

Published:2019-03-13 Issue:1 Volume:9 Page:
ISSN:2191-219X
Container-title:EJNMMI Research
language:en
Short-container-title:EJNMMI Res

Author:

Smeets Esther M. M.,Withaar Dominique S.,Grootjans Willem,Hermans John J.,van Laarhoven Kees,de Geus-Oei Lioe-Fee,Gotthardt Martin,Aarntzen Erik H. J. G.^ORCID

Funder

KWF Kankerbestrijding

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1186/s13550-019-0492-y.pdf

Reference40 articles.

1. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371(22):2140–1.

2. Conroy T, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–25.

3. Von Hoff DD, et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol. 2011;29(34):4548–54.